Jennison Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
|
|||||
|
2025
Q1 | $320M | Buy |
|
|||||
|
2024
Q4 | $207M | Sell |
|
|||||
|
2024
Q3 | $219M | Buy |
|
|||||
|
2024
Q2 | $33.9M | Sell |
|
|||||
|
2024
Q1 | $57.8M | Sell |
|
|||||
|
2023
Q4 | $71.5M | Sell |
|
|||||
|
2023
Q3 | $219M | Buy |
|
|||||
|
2023
Q2 | $195M | Sell |
|
|||||
|
2023
Q1 | $224M | Sell |
|
|||||
|
2022
Q4 | $244M | Sell |
|
|||||
|
2022
Q3 | $275M | Sell |
|
|||||
|
2022
Q2 | $315M | Sell |
|
|||||
|
2022
Q1 | $396M | Buy |
|
|||||
|
2021
Q4 | $219M | Buy |
|
|||||
|
2021
Q3 | $107M | Sell |
|
|||||
|
2021
Q2 | $123M | Buy |
|
|||||
|
2021
Q1 | $94.4M | Sell |
|
|||||
|
2020
Q4 | $114M | Buy |
|
|||||
|
2020
Q3 | $105M | Buy |
|
|||||
|
2020
Q2 | $99.8M | Buy |
|
|||||
|
2020
Q1 | $67.7M | Buy |
|
|||||
|
2019
Q4 | $38M | Sell |
|
|||||
|
2019
Q3 | $39.8M | Sell |
|
|||||
|
2019
Q2 | $41.2M | Sell |
|
|||||
|
2019
Q1 | $600M | Buy |
|
|||||
|
2018
Q4 | $579M | Sell |
|
|||||
|
2018
Q3 | $1.34B | Buy |
|
|||||
|
2018
Q2 | $965M | Sell |
|
|||||
|
2018
Q1 | $1.66B | Buy |
|
|||||
|
2017
Q4 | $1.51B | Sell |
|
|||||
|
2017
Q3 | $1.71B | Buy |
|
|||||
|
2017
Q2 | $1.29B | Buy |
|
|||||
|
2017
Q1 | $1.19B | Buy |
|
|||||
|
2016
Q4 | $1.27B | Buy |
|
|||||
|
2016
Q3 | $985M | Sell |
|
|||||
|
2016
Q2 | $2.06B | Buy |
|
|||||
|
2016
Q1 | $1.72B | Sell |
|
|||||
|
2015
Q4 | $1.91B | Buy |
|
|||||
|
2015
Q3 | $1.38B | Sell |
|
|||||
|
2015
Q2 | $1.83B | Sell |
|
|||||
|
2015
Q1 | $1.85B | Sell |
|
|||||
|
2014
Q4 | $1.72B | Buy |
|
|||||
|
2014
Q3 | $1.39B | Buy |
|
|||||
|
2014
Q2 | $1.15B | Sell |
|
|||||
|
2014
Q1 | $1.51B | Sell |
|
|||||
|
2013
Q4 | $1.59B | Buy |
|
|||||
|
2013
Q3 | $714M | Sell |
|
|||||
|
2013
Q2 | $765M | Buy |
|